Home
Platforms
Immediate Stabilisation System (ISS)
Extra Cellular Matrix (ECM) Coating
Bisphosponate Coating (BCP)
About us
Operative Team
Member of Clinical & Medical Advisory Board
Board of Directors
Contact
Terms of Use & privacy statement
Home
Platforms
Immediate Stabilisation System (ISS)
Extra Cellular Matrix (ECM) Coating
Bisphosponate Coating (BCP)
About us
Operative Team
Member of Clinical & Medical Advisory Board
Board of Directors
Contact
Terms of Use & privacy statement
​BISPHOSPHONATE COATING PLATFORM (BCP)
Goal
To improve long-term stabilisation of orthopaedic implants
Concept
Coating technology that allows coating of implants with bisphosphonates
Leading to significantly improved long-term stabilisation of implants as bisphosphonates block osteoclastic activity
Technology
Simply and easy-to-use coating process
Allowing deposition of bisphosphonates on all implant surfaces
Technology platform can be used as a drug delivery system
USP
Platform technology without any change of original implants
One-phase system: carrier = drug
No linker, no toxic side effects
Release can be adjusted
Independent of the substrate material
Gamma & EtO sterilisable
Low-cost technology
Schematic diagram of Nexilis propietary one phase system coating